Cargando…

Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR‐SB

There is strong interest in developing predictive models to better understand individual heterogeneity and disease progression in Alzheimer's disease (AD). We have built upon previous longitudinal AD progression models, using a nonlinear, mixed‐effect modeling approach to predict Clinical Demen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jamalian, Samira, Dolton, Michael, Chanu, Pascal, Ramakrishnan, Vidya, Franco, Yesenia, Wildsmith, Kristin, Manser, Paul, Teng, Edmond, Jin, Jin Y., Quartino, Angelica, Hsu, Joy C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349194/ https://www.ncbi.nlm.nih.gov/pubmed/37101394 http://dx.doi.org/10.1002/psp4.12974

Ejemplares similares

Modeling Alzheimer's Disease Progression Using Disease Onset Time and Disease Trajectory Concepts Applied to CDR-SOB Scores From ADNI
por: Delor, I, et al.
Publicado: (2013)

Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clinical candidates
por: Ramakrishnan, Vidya, et al.
Publicado: (2022)

Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial
por: Teng, Edmond, et al.
Publicado: (2022)

Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI
por: Ding, Xiuhua, et al.
Publicado: (2019)

Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet
por: Monteiro, Cecilia, et al.
Publicado: (2023)

A voxel-based morphometry comparison of the 3.0T ADNI-1 and ADNI-2 volumetric MRI protocols
por: Brunton, Simon, et al.
Publicado: (2015)

Imago Mundi, Imago AD, Imago ADNI
por: Villemagne, Victor L, et al.
Publicado: (2014)

Clinical and multimodal biomarker correlates of ADNI neuropathological findings
por: Toledo, Jon B, et al.
Publicado: (2013)

Development and validation of language and visuospatial composite scores in ADNI
por: Choi, Seo‐Eun, et al.
Publicado: (2020)

Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer’s Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated
por: Barthélemy, Nicolas R., et al.
Publicado: (2022)

Baseline [(18)F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
por: Teng, Edmond, et al.
Publicado: (2021)

Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort
por: Chen, Dandan, et al.
Publicado: (2023)

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition
por: Toledo, Jon B, et al.
Publicado: (2014)

Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNI
por: Windon, Charles, et al.
Publicado: (2022)

Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2
por: Edgar, Chris J., et al.
Publicado: (2021)

The CLIC ILD CDR Geometry for the CDR Monte Carlo Mass Production
por: Muennich, A, et al.
Publicado: (2012)

Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration
por: Herdlevær, Ida, et al.
Publicado: (2020)

CDR update report
por: Yin, Ting
Publicado: (2019)

β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3
por: Bourgeat, Pierrick, et al.
Publicado: (2022)

Population Pharmacokinetics and Exposure‐Response Relationships of Astegolimab in Patients With Severe Asthma
por: Kotani, Naoki, et al.
Publicado: (2022)

Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
por: Risacher, Shannon L, et al.
Publicado: (2009)

Systematic comparison of different techniques to measure hippocampal subfield volumes in ADNI2
por: Mueller, Susanne G., et al.
Publicado: (2017)

Targeted metabolomics and medication classification data from participants in the ADNI1 cohort
por: St John-Williams, Lisa, et al.
Publicado: (2017)

Cognitive dedifferentiation as a function of cognitive impairment in the ADNI and MemClin cohorts
por: Wallert, John, et al.
Publicado: (2021)

Glucose hypometabolism in the Auditory Pathway in Age Related Hearing Loss in the ADNI cohort
por: Zainul Abidin, Fatin N., et al.
Publicado: (2021)

Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNI
por: Shishegar, Rosita, et al.
Publicado: (2021)

The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives
por: Weber, Christopher J., et al.
Publicado: (2021)

Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort
por: Liu, Yi, et al.
Publicado: (2022)

CDR Update for NA62
por: Yin, Ting
Publicado: (2019)

The CDR subsystem of the COMPASS experiment
por: Král, A, et al.
Publicado: (2005)

Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study
por: Swaminathan, Shanker, et al.
Publicado: (2011)

Relationship between Plasma Analytes and SPARE-AD Defined Brain Atrophy Patterns in ADNI
por: Toledo, Jon B., et al.
Publicado: (2013)

Examining the role of repeated test exposure over 12 months across ADNI protocols
por: Hammers, Dustin B., et al.
Publicado: (2022)

Local Atrophy Observed in Subjective Cognitive Decline Varies Based on Questionnaire Employed in ADNI
por: Morrison, Cassandra, et al.
Publicado: (2021)

An Alzheimer’s disease category progression sub-grouping analysis using manifold learning on ADNI
por: van der Haar, Dustin, et al.
Publicado: (2023)

Correction to: Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort
por: Liu, Yi, et al.
Publicado: (2022)

The CLIC SiD CDR Detector Model for the CLIC CDR Monte Carlo Mass Production
por: Grefe, C, et al.
Publicado: (2011)

Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis
por: Schubert, Manja, et al.
Publicado: (2014)

On the decay of 110Sb, 111Sb, 112Sb, 113Sb and 114Sb
por: Sunier, J W, et al.
Publicado: (1970)

Multi Step Selection in Ig H Chains is Initially Focused on CDR3 and Then on Other CDR Regions
por: Liberman, Gilad, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0hq62b9oanlt8licqdsm4egdg7